UB Paderborn / Katalog / Suche / in CDI

Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis

Pharmacology & therapeutics (Oxford), 2008-01, Vol.117 (1), p.77-93

2008

Link zum Volltext

Verfügbarkeit prüfen

Design and Synthesis of Selurampanel, a Novel Orally Active and Competitive AMPA Receptor Antagonist

ChemMedChem, 2017-02, Vol.12 (3), p.197-201

2017

Link zum Volltext

Verfügbarkeit prüfen

Design and Synthesis of Selective and Potent Orally Active S1P5 Agonists

ChemMedChem, 2010-10, Vol.5 (10), p.1693-1696

2010

Link zum Volltext

Verfügbarkeit prüfen

Crystal Structure of NLRP3 NACHT Domain With an Inhibitor Defines Mechanism of Inflammasome Inhibition

Journal of molecular biology, 2021-12, Vol.433 (24), p.167309-167309, Article 167309

2021

Link zum Volltext

Verfügbarkeit prüfen

Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation Model

Journal of medicinal chemistry, 2018-08, Vol.61 (15), p.6724-6735

2018

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Biological Evaluation of New Triazolo- and Imidazolopyridine RORγt Inverse Agonists

ChemMedChem, 2016-12, Vol.11 (24), p.2640-2648

2016

Link zum Volltext

Verfügbarkeit prüfen

The Crystal Structure of Cancer Osaka Thyroid Kinase Reveals an Unexpected Kinase Domain Fold

The Journal of biological chemistry, 2015-06, Vol.290 (24), p.15210-15218

2015

Link zum Volltext

Verfügbarkeit prüfen

α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Antagonists: From Bench to Bedside

Journal of medicinal chemistry, 2010-08, Vol.53 (15), p.5367-5382

2010

Link zum Volltext

Verfügbarkeit prüfen

Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors

Journal of medicinal chemistry, 2016-08, Vol.59 (16), p.7544-7560

2016

Link zum Volltext

Verfügbarkeit prüfen

The Serotonin 5-HT4 Receptor. 2. Structure-Activity Studies of the Indole Carbazimidamide Class of Agonists

Journal of medicinal chemistry, 1995-06, Vol.38 (13), p.2331-2338

1995

Link zum Volltext

Verfügbarkeit prüfen

AMPA receptor antagonists: potential therapeutic applications

Recent patents on CNS drug discovery, 2006-11, Vol.1 (3), p.247

2006

Link zum Volltext

Verfügbarkeit prüfen

Identification of a Potent Agonist of the Orphan Nuclear Receptor Nurr1

ChemMedChem, 2006-09, Vol.1 (9), p.955-958

2006

Link zum Volltext

Verfügbarkeit prüfen

The Serotonin 5-HT4 Receptor. 1. Design of a New Class of Agonists and Receptor Map of the Agonist Recognition Site

Journal of medicinal chemistry, 1995-06, Vol.38 (13), p.2326-2330

1995

Link zum Volltext

Verfügbarkeit prüfen

Cover Picture: Design and Synthesis of Selurampanel, a Novel Orally Active and Competitive AMPA Receptor Antagonist (ChemMedChem 3/2017)

ChemMedChem, 2017-02, Vol.12 (3), p.196-196

2017

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Biological Evaluation of New Triazolo- and Imidazolopyridine ROR[gamma]t Inverse Agonists

ChemMedChem, 2016-12, Vol.11 (24), p.2640-2648

2016

Link zum Volltext

Verfügbarkeit prüfen

Quinazolinedione sulfonamides: A novel class of competitive AMPA receptor antagonists with oral activity

Bioorganic & medicinal chemistry letters, 2011-06, Vol.21 (11), p.3358-3361

2011

Link zum Volltext

Verfügbarkeit prüfen

6-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonists

Bioorganic & medicinal chemistry letters, 2012-01, Vol.22 (2), p.996-999

2012

Link zum Volltext

Verfügbarkeit prüfen

Discovery of novel non-peptidic beta-alanine piperazine amide derivatives and their optimization to achiral, easily accessible, potent and selective somatostatin sst1 receptor antagonists

Bioorganic & medicinal chemistry letters, 2009-03, Vol.19 (5), p.1305-1309

2009

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of imidazole phosphinic acids as I4AA analogues

Tetrahedron letters, 2006-02, Vol.47 (8), p.1253-1255

2006

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of Two New Azabicyclophosphinic Acids as Constrained Analogues of TPMPA

Synlett, 2005-12, Vol.2005 (19), p.3008-3010

2005

Link zum Volltext

Verfügbarkeit prüfen

Discovery of novel non-peptidic β-alanine piperazine amide derivatives and their optimization to achiral, easily accessible, potent and selective somatostatin sst 1 receptor antagonists

Bioorganic & medicinal chemistry letters, 2009, Vol.19 (5), p.1305-1309

2009

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of a model hapten with cyclohexanediol and .alpha.-methylene-.gamma.-butyrolactone groups, a synthetic analog of poison ivy and tulipalin allergens connected with a carbon chain

Journal of organic chemistry, 1988-06, Vol.53 (12), p.2732-2737

1988

Link zum Volltext

Verfügbarkeit prüfen

Inside Cover: Design and Synthesis of Selective and Potent Orally Active S1P5 Agonists (ChemMedChem 10/2010)

ChemMedChem, 2010-10, Vol.5 (10), p.1638-1638

2010

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum: Design and Synthesis of Selective and Potent Orally Active S1P5 Agonists

ChemMedChem, 2010-10, Vol.5 (10), p.1646-1646

2010

Link zum Volltext

Verfügbarkeit prüfen

Two amino acids, located in transmembrane domains VI and VII, determine the selectivity of the peptide agonist SMS 201‐995 for the SSTR2 somatostatin receptor

The EMBO journal, 1995-02, Vol.14 (4), p.727-735

1995

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis

Design and Synthesis of Selurampanel, a Novel Orally Active and Competitive AMPA Receptor Antagonist

Design and Synthesis of Selective and Potent Orally Active S1P5 Agonists

Crystal Structure of NLRP3 NACHT Domain With an Inhibitor Defines Mechanism of Inflammasome Inhibition

Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation Model

Synthesis and Biological Evaluation of New Triazolo- and Imidazolopyridine RORγt Inverse Agonists

The Crystal Structure of Cancer Osaka Thyroid Kinase Reveals an Unexpected Kinase Domain Fold

α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Antagonists: From Bench to Bedside

Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors

The Serotonin 5-HT4 Receptor. 2. Structure-Activity Studies of the Indole Carbazimidamide Class of Agonists

AMPA receptor antagonists: potential therapeutic applications

Identification of a Potent Agonist of the Orphan Nuclear Receptor Nurr1

The Serotonin 5-HT4 Receptor. 1. Design of a New Class of Agonists and Receptor Map of the Agonist Recognition Site

Cover Picture: Design and Synthesis of Selurampanel, a Novel Orally Active and Competitive AMPA Receptor Antagonist (ChemMedChem 3/2017)

Synthesis and Biological Evaluation of New Triazolo- and Imidazolopyridine ROR[gamma]t Inverse Agonists

Quinazolinedione sulfonamides: A novel class of competitive AMPA receptor antagonists with oral activity

6-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonists

Discovery of novel non-peptidic beta-alanine piperazine amide derivatives and their optimization to achiral, easily accessible, potent and selective somatostatin sst1 receptor antagonists

Synthesis of imidazole phosphinic acids as I4AA analogues

Synthesis of Two New Azabicyclophosphinic Acids as Constrained Analogues of TPMPA

Discovery of novel non-peptidic β-alanine piperazine amide derivatives and their optimization to achiral, easily accessible, potent and selective somatostatin sst 1 receptor antagonists

Synthesis of a model hapten with cyclohexanediol and .alpha.-methylene-.gamma.-butyrolactone groups, a synthetic analog of poison ivy and tulipalin allergens connected with a carbon chain

Inside Cover: Design and Synthesis of Selective and Potent Orally Active S1P5 Agonists (ChemMedChem 10/2010)

Corrigendum: Design and Synthesis of Selective and Potent Orally Active S1P5 Agonists

Two amino acids, located in transmembrane domains VI and VII, determine the selectivity of the peptide agonist SMS 201‐995 for the SSTR2 somatostatin receptor

Suchergebnisse filtern